Understanding the dual role of PLXNB2 in both tumor cell adhesion and immune cell dynamics could offer new therapeutic strategies aimed at disrupting these processes to reduce metastasis and improve patient outcomes. The gene discussed is PLXNB2; the disease is neoplasm.